mitoxantrone has been researched along with Leukemia, Prolymphocytic in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Leukemia, Prolymphocytic: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valiev, TT | 1 |
| Vinogradova, IuE | 1 |
| Chernova, NG | 1 |
| Mar'in, DS | 1 |
| Volkova, IaK | 1 |
| Petrova, VI | 1 |
| Bulanov, AIu | 1 |
| Kalinin, NN | 1 |
| Semenova, EA | 1 |
| Gretsov, EM | 1 |
| Kravchenko, SK | 1 |
| Kremenetskaia, AM | 1 |
| Vorob'ev, AI | 1 |
| Styczynski, J | 1 |
| Pieters, R | 1 |
| Huismans, DR | 1 |
| Schuurhuis, GJ | 1 |
| Wysocki, M | 1 |
| Veerman, AJ | 1 |
2 other studies available for mitoxantrone and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Prolymphocytic; | 2006 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child | 2000 |